Clinical Trial Update: Combination of Metformin With Gefitinib to Treat NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating metformin in combination with gefitinib for non-small cell lung cancer has completed. The update notes the study status and suggests ex…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gefitinib (Gefitinib)
• metformin (metformin)

Snippet

Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Conditions: NSCLC, EGFR Gene Amplification | Phase 2 | Status: COMPLETED